Stock Markets

Apr. 17, 2026

Zenas BioPharma Short Interest Surges 21% in March

Biotech firm faces increased short selling activity amid market volatility

Apr. 16, 2026

Vera Therapeutics CEO Sells Over 22,000 Shares

Marshall Fordyce cashes out a portion of his stake in the biotech company.

Apr. 16, 2026

Short Interest in Monte Rosa Therapeutics Rises 22.2%

Shares of the biotech company see increased short selling activity

Apr. 16, 2026

HC Wainwright Reaffirms 'Sell' Rating for Sarepta Therapeutics

Investment firm maintains bearish outlook on biotech company's stock

Apr. 16, 2026

Compass Therapeutics Stock Rises 7.4% on Positive News

The biotech company's shares jump after strong analyst ratings and institutional investor activity.

Apr. 16, 2026

Sarepta Therapeutics Stock Surges Above 200-Day Average

Shares of the biotech firm rise as analysts weigh in on the company's prospects

Apr. 16, 2026

Vera Therapeutics Stock Earns 'Moderate Buy' Rating from Analysts

Biotech firm's shares receive consensus recommendation from 12 research analysts

Apr. 15, 2026

Vera Therapeutics CEO Sells Over $1 Million in Stock

Marshall Fordyce sold nearly 23,000 shares under a pre-arranged trading plan

Apr. 14, 2026

JonesTrading Initiates Coverage on Relay Therapeutics

Analysts set a 'hold' rating and $18 price target on the biotech stock.

Apr. 14, 2026

EverQuote Director Sells $10,659 in Stock

George Neble reduces stake by 1.28% in online insurance marketplace

Apr. 14, 2026

Addex Therapeutics Short Interest Drops in March

The biopharmaceutical company's stock saw a significant decline in short positions last month.

Apr. 13, 2026

Analysts Bullish on Edgewise Therapeutics Stock

Firm's novel kidney disease drug candidate shows promise, boosting price targets

Apr. 13, 2026

Synlogic and Novavax Face Off in Financial Analysis

Two small-cap biotech firms compete on institutional ownership, profitability, and more

Apr. 13, 2026

Citigroup Cuts Biogen Price Target

Biotech firm's stock rating remains neutral despite target reduction

Apr. 13, 2026

Robeco Institutional Asset Management Trims Stake in ARM Holdings

The asset management firm reduced its position in the semiconductor IP company by 1% in Q4 2025.

Apr. 12, 2026

Curbstone Financial Acquires Stake in Pegasystems

Investment firm adds new position in technology company

Apr. 12, 2026

Massachusetts Financial Firm Reduces Stake in Pegasystems

Institutional investor sells over 59,000 shares of tech company's stock

Apr. 12, 2026

Relay Therapeutics CFO Sells $27,000 in Stock

Catinazzo's sale represents a 0.83% decrease in his position

Apr. 12, 2026

Black Diamond Therapeutics Receives 'Moderate Buy' Rating from Analysts

The biotech company's stock has a consensus recommendation and average target price from Wall Street analysts.